ロード中...
Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment
Two open‐label studies assessed the safety, tolerability, and pharmacokinetics of Oxbryta (voxelotor) in subjects with hepatic or renal impairment. Eight subjects with severe renal impairment (estimated glomerular filtration rate <30 mL/min/1.73 m(2)) and 8 healthy age‐, sex‐, and body mass index...
保存先:
| 出版年: | J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984382/ https://ncbi.nlm.nih.gov/pubmed/33084052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1757 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|